Immunosuppression < Immunosuppressive Agents < Immunotherapy

Facettes : AffPays.f Mesh.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 35.
[0-20] [0 - 20][0 - 35][20-34][20-40]

Ident.	Authors (with country if any)	Title
000005 (1999)	M M Saeed [États-Unis] ; M S Woo ; E F Maclaughlin ; M F Margetis ; T G Keens	Prognosis in pediatric idiopathic pulmonary hemosiderosis.
000007 (2000)	M. Marschalk [Hongrie] ; G. P Nyai ; E. Ablonczy ; A. Horváth	[Dermatomyositis: clinical study of 34 patients].
000017 (2000)	M. Austin Taylor [États-Unis] ; M. Bennett ; V. Kumar ; J D Schatzle	Functional defects of NK cells treated with chloroquine mimic the lytic defects observed in perforin-deficient mice.
000035 (2003)	R P Baughman [États-Unis] ; J P Lynch	Difficult treatment issues in sarcoidosis.
000036 (2003)	S. Paramothayan ; T. Lasserson ; E H Walters	Immunosuppressive and cytotoxic therapy for pulmonary sarcoidosis.
000037 (2003)	Ahmed S. Samad [États-Unis] ; Carol B. Lindsley	Treatment of pulmonary hemorrhage in childhood systemic lupus erythematosus with mycophenolate mofetil.
000061 (2003)	Piera Fazzi [Italie]	Pharmacotherapeutic management of pulmonary sarcoidosis.
000091 (2006)	S. Paramothayan ; T J Lasserson ; E H Walters	Immunosuppressive and cytotoxic therapy for pulmonary sarcoidosis.
000106 (2008)	Shanthi Paramothayan [Royaume-Uni] ; Toby Lasserson	Treatments for pulmonary sarcoidosis.
000140 (2010)	Keith C. Meyer [États-Unis] ; Catherine Decker ; Robert Baughman	Toxicity and monitoring of immunosuppressive therapy used in systemic autoimmune diseases.
000148 (2011)	Jozélio Freire De Carvalho [Brésil] ; Licia Maria Henrique Da Mota ; Eloisa Bonfa	Fatal rhabdomyolysis in systemic lupus erythematosus.
000164 (2012)	M. Aringer [Allemagne] ; H. Burkhardt ; G R Burmester ; R. Fischer-Betz ; M. Fleck ; W. Graninger ; F. Hiepe ; A M Jacobi ; I. Kötter ; H J Lakomek ; H M Lorenz ; B. Manger ; G. Schett ; R E Schmidt ; M. Schneider ; H. Schulze-Koops ; J S Smolen ; C. Specker ; T. Stoll ; A. Strangfeld ; H P Tony ; P M Villiger ; R. Voll ; T. Witte ; T. Dörner	Current state of evidence on 'off-label' therapeutic options for systemic lupus erythematosus, including biological immunosuppressive agents, in Germany, Austria and Switzerland--a consensus report.
000174 (2013)	Frances Flanagan [Irlande (pays)] ; Louisa Glackin ; Dubhfeasa M. Slattery	Successful treatment of idiopathic pulmonary capillaritis with intravenous cyclophosphamide.
000180 (2012)	Sarah B. Goldberg [États-Unis] ; Jeffrey G. Supko ; Joel W. Neal ; Alona Muzikansky ; Subba Digumarthy ; Panos Fidias ; Jennifer S. Temel ; Rebecca S. Heist ; Alice T. Shaw ; Patricia O. Mccarthy ; Thomas J. Lynch ; Sreenath Sharma ; Jeffrey E. Settleman ; Lecia V. Sequist	A phase I study of erlotinib and hydroxychloroquine in advanced non-small-cell lung cancer.
000188 (2013)	Holger Meinicke [Allemagne] ; Andrea Heinzmann ; Julia Geiger ; Reinhard Berner ; Markus Hufnagel	Symptoms of shrinking lung syndrome reveal systemic lupus erythematosus in a 12-year-old girl.
000207 (2013)	Duygu Emine Ersozlu Bozkirli [Turquie] ; Ilknur Kozanoglu ; Emre Bozkirli ; Eftal Yucel	Antisynthetase syndrome with refractory lung involvement and myositis successfully treated with double filtration plasmapheresis.
000212 (2013)	V L S. Marques [Brésil] ; R C Gomes ; G R Viola ; M M Maia ; G S Durigon ; N E Aikawa ; C. Artur Silva	Pulmonary cryptococcosis in childhood systemic lupus erythematosus and Sjögren syndrome overlap: a rare opportunistic infection.
000215 (2014)	Michael Williamson [Royaume-Uni] ; Colin Wallis	Ten-year follow up of hydroxychloroquine treatment for ABCA3 deficiency.
000256 (2014)	Adriane D M. Vorselaars ; Johanna P. Cremers ; Jan C. Grutters ; Marjolein Drent	Cytotoxic agents in sarcoidosis: which one should we choose?
000285 (2015)	Águeda Prior-Espa Ol [Espagne] ; Melania Martínez-Morillo [Espagne] ; Anne Riveros-Frutos [Espagne] ; Alejandro Olivé [Espagne]	[Recurrent diffuse alveolar hemorrhage in systemic lupus erytematosus treated with rituximab and immunoglobulins].
000288 (2015)	Sarah K. Brode [Canada] ; Frances B. Jamieson [Canada] ; Ryan Ng [Canada] ; Michael A. Campitelli [Canada] ; Jeffrey C. Kwong [Canada] ; J Michael Paterson [Canada] ; Ping Li [Canada] ; Alex Marchand-Austin [Canada] ; Claire Bombardier [Canada] ; Theodore K. Marras [Canada]	Increased risk of mycobacterial infections associated with anti-rheumatic medications.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/Mesh.i -k "Immunosuppressive Agents" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/Mesh.i  \
                -Sk "Immunosuppressive Agents" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Immunosuppressive Agents
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021